Call for Abstract

ABSTRACT SUBMISSION

Abstract submission system will be available by February 21st, 2011. The only valid way to submit papers into the system is via the official website www.icllm2011.org. Papers that are sent through e-mail or surface mail will not be admitted. Papers will be selected as oral presentations or poster presentations by the Scientific Evaluation Committee.

Guidelines for preparation and submission of abstract

1. The space allocated for paper abstract in the system is limited to 3000 characters. The system will not allow you to type in more than 3000 characters in this space.
2. Abstracts must be submitted in English.
3. Authors who will present a paper must be registered as participants.
4. The fonts you will use to submit your paper abstract is determined by the system by default for all papers. It is not possible to use another font.
5. Headline (Title) should be written capital letters except for special names as pH, NaCI etc.
6. Standard abbreviations are accepted. If any special abbreviations are used, they should be written in fully in parentheses the first time they appear in the text.
7. Medicine names should be written as first letter capital and prefered to use general names of medicine.
8. Abstracts may include one illustration and two tables.
9. Abstracts should contain objectives, methods, results and conclusion. Bibliography should be added end of the abstract.
10. The final date for submitting the paper abstract is February 7th, 2011.

Notification
The reply indicating whether or not the abstract is accepted will be given by e-mail. If necessary, you may contact Serenas Tourism. The list of accepted abstracts will be published on the website of www.icllm2011.org .

Posters
Posters must have width of 70 cm and height of 90 cm, and they shall be prepared in such a way to allow reading from at least 1 meter distance. Poster will be displayed on the boards on the specified dates as determined by the Evaluation Committee. Posters will be displayed between the specified hours on the predetermined date, and they will be removed after that hour. Posters that are not removed after the specified hour will be removed by the organization secretary. While the posters are being put on display, congress personel will be available to assist those who have a poster presentation.

The Best Five Abstracts Awards
This year five registrants who submit high-quality abstracts will be awarded.

Award-Winning Abstracts

28	NON-HODGKIN'S LYMPHOMA	MOLECULAR GENE PROFILING FOR THE TREATMENT OF DIFFUSE LARGE B CELL LYMPHOMA IN TURKISH POPULATION	Melike Ozturk	Turkey
32	CHRONIC LYMPHOCYTIC LEUKEMIA	THE CLINICAL FEATURES OF 105 CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS FOLLOWED UP AT A SINGLE CENTER	Gülsüm Emel Pamuk	Turkey
50	ACUTE LYMPHOBLASTIC LEUKEMIA	Toll-like 4 (TLR-4), NOD2, Dectin-1 polymorphisms and susceptibility to infections, relapse and other complications in children with acute lymphoblastic leukemia	Nihal Özdemir	Turkey
106	MULTIPLE MYELOMA	Zoledronic Acid (ZOL) and Thalidomide (Thal) Combinations Improved Overall Survival (OS) and Bone Endpoints in the MRC Myeloma IX Trial: Optimising Bisphosphonate (BP) and Antimyeloma Therapies	Catherine Browning	United States
120	ACUTE MYELOBLASTIC LEUKEMIA	MAY PERIPHERAL BLOOD WT1 MRNA EXPRESSION LEVELS PREDICT MINIMAL RESIDUAL DISEASE (MRD) IN PATIENTS WITH NEWLY DIAGNOSED ACUTE LEUKEMIA?	Serdar Şıvgın	Turkey